Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study
Chétana Lim(Hôpitaux Universitaires Henri-Mondor), Alessandro Ferrero, Fernando Rotellar(Universidad de Navarra), Raffaele Brustia(Assistance Publique – Hôpitaux de Paris), Constantino Fondevila(Hospital Clínic de Barcelona), Kazuteru Monden(Far Eastern Memorial Hospital), Davit L. Aghayan(Oslo University Hospital), Sung Hoon Choi(NorthShore University HealthSystem), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Jasper P. Sijberden(Fondazione Poliambulanza Istituto Ospedaliero), Adrian Kah Heng Chiow(Changi General Hospital), Andrea Ruzzenente(University of Verona), Mikel Prieto(University of the Basque Country), Andrea Belli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Marco Vivarelli(Marche Polytechnic University), Olivier Scatton(Université Paris-Saclay), Wanguang Zhang(Tongji Hospital), Charing C. N. Chong(National University of Singapore), Santiago López‐Ben(Hospital Universitari de Girona Doctor Josep Trueta), Михаил Ефанов(Singapore General Hospital), R Robles(Hospital Universitario Virgen de la Arrixaca), Salvatore Gruttadauria, Riccardo Memeo(Libera Università Maria SS. Assunta), Ugo Boggi(University of Pisa), Zenichi Morise(Fujita Health University), David A. Geller(University of Pittsburgh Medical Center), James O. Park(University of Washington Medical Center), Federica Cipriani(Vita-Salute San Raffaele University), Alejandro Mejia(Methodist Dallas Medical Center), Iswanto Sucandy(AdventHealth Tampa), Tiing-Foong Siow(National Taiwan University), Kiyoshi Hasegawa(Bunkyo University), Paulo Herman(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Mengqiu Yin(Zhejiang University), Gi Hong Choi(Yonsei University), Raffaele Dalla Valle(University of Parma), Andrew G. R. Wu(National University of Singapore), T. Peter Kingham(Memorial Sloan Kettering Cancer Center), Marco V. Marino(Oslo University Hospital), Felice Giuliante(Università Cattolica del Sacro Cuore), Robert P. Sutcliffe(University Hospitals Birmingham NHS Foundation Trust), Johann Pratschke(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jae Hoon Lee(Ulsan College), Eric C. H. Lai(Second Military Medical University), Safi Dokmak(Hôpital Beaujon), Chee-Chien Yong(Seoul National University Hospital), Arpad Ivanecz(Seoul National University Hospital), Xiaoying Wang(Fudan University), Mathieu D’Hondt(AZ Groeninge)
Cited by 7
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712